V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20047349 | 20086354 | 1.73 | 78.45 | Palliative (P) | 2016-09-10 | 2016-09-13 | ACELARATE Trial | null | N | CAPECITABINE + CETUXIMAB + IRINOTECAN | 100270427 |
| 20047364 | 20086355 | 1.71 | 62 | null | 2019-08-05 | 2019-08-08 | ARISTOTLE TRIAL | 02 | N | GEMCARBO | 101479993 |
| 20047383 | 20086356 | 1.66 | 52.55 | null | 2021-09-10 | 2021-09-14 | Rituximab (Maintenance) | 1 | N | CISPLATIN + FLUOROURACIL + RT | 101370776 |
| 20047405 | 20086357 | 1.73 | 130 | Palliative (P) | 2017-10-28 | 2017-10-28 | Cyclophosphamide + Docetaxel | 02 | N | BENDAMUSTINE + RITUXIMAB | 100560058 |
| 20047428 | 20086358 | 1.71 | 64 | 03 | 2021-02-11 | 2021-03-04 | Capecitabine+Cisplatin+Streptozocin | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101425042 |
| 20047432 | 20086359 | 1.76 | 58 | 03 | null | 2019-04-27 | CYCLOPHOSPHAMIDE + EPIRUBICIN | null | Y | HYDROXYCARBAMIDE | 101205070 |
| 20047460 | 20086360 | null | null | 03 | 2018-12-22 | 2018-12-31 | Gemcitabine+Paclitaxel (Neo-tAnGo) | N | N | CAPECITABINE + STREPTOZOCIN | 101234913 |
| 20047501 | 20086361 | 1.5 | 107 | 03 | 2019-01-19 | 2019-02-12 | MELPHALAN + THALIDOMIDE | 02 | N | OXALIPLATIN | 101580410 |
| 20047528 | 20086362 | 1.81 | 72.8 | 03 | 2020-06-20 | 2020-06-28 | null | N | N | IRINOTECAN | 101519418 |
| 20047550 | 20086363 | 1.6 | null | Palliative (P) | 2018-12-04 | 2018-12-25 | ARISTOTLE TRIAL | 02 | N | GEMCARBO | 101836572 |
| 20047578 | 20086364 | 1.81 | 78.8 | Palliative (P) | 2017-06-19 | 2017-07-03 | ARISTOTLE TRIAL | 02 | N | ECARBOX | 101274177 |
| 20047692 | 20086365 | 1.56 | 91.4 | Neo-adjuvant (N) | 2019-07-29 | 2019-08-02 | CVP R | 01 | N | CHOP | 100445160 |
| 20047726 | 20086366 | 1.77 | 73 | 03 | 2021-04-08 | 2021-04-21 | HEP HR Hepatoblastoma guide cisp | N | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101130665 |
| 20047893 | 20086368 | 1.57 | 57.25 | 03 | 2019-11-27 | 2020-01-12 | EVEROLIMUS | 02 | N | ESPAC TRIAL | 100277209 |
| 20047911 | 20086370 | 1.71 | 67.4 | 03 | 2019-11-15 | 2019-12-12 | Everolimus 10mg | 02 | N | NAB-PACLITAXEL | 100129227 |
| 20047927 | 20086371 | 1.59 | 64 | Palliative (P) | 2019-08-21 | 2019-09-03 | Panitumumab | Y | N | ACELARATE TRIAL | 101012006 |
| 20047941 | 20086372 | 1.65 | 108 | Palliative (P) | 2018-07-03 | 2018-07-09 | PLATO Trials | N | Y | PLATO TRIAL | 101332556 |
| 20047955 | 20086373 | 1.82 | 68.4 | Adjuvant (A) | 2017-12-14 | 2018-01-05 | Raltitrexed | 02 | N | NOT MATCHED | 101411627 |
| 20047960 | 20086374 | 1.76 | 69.65 | Palliative (P) | 2017-12-29 | 2017-12-30 | CVP R | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100307045 |
| 20047971 | 20086375 | 1.75 | 77 | Palliative (P) | 2016-12-27 | 2016-12-29 | OXALIPLATIN | 02 | N | PHITT C CARBOPLATIN/DOXORUBICIN | 100754393 |
| 20048023 | 20086376 | 1.75 | 71 | Palliative (P) | 2018-09-15 | 2018-10-04 | OXALIPLATIN | 02 | N | FLUOROURACIL + RT | 100262178 |
| 20048114 | 20086377 | 0 | 0 | Palliative (P) | 2017-10-12 | 2017-10-13 | Raltitrexed | 02 | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 101694154 |
| 20048144 | 20086378 | 1.76 | 65.95 | Curative (C) | 2017-10-24 | 2017-11-16 | Cisplatin + Vinorelbine (PO) | N | N | GEMCITABINE + PACLITAXEL | 101147536 |
| 20048231 | 20086379 | 1.54 | 70.2 | 03 | 2016-10-16 | 2016-10-28 | Cisplatin + Fluorouracil + RT 5day | 02 | N | EVEROLIMUS | 101616964 |
| 20048247 | 20086380 | 1.55 | 74.9 | null | 2017-07-06 | 2017-07-06 | SCOPE 1 TRIAL | 02 | N | IRINOTECAN | 100819759 |
| 20048274 | 20086381 | 1.81 | 56 | Palliative (P) | null | 2017-06-03 | DABRAFENIB | 2 | N | ARISTOTLE TRIAL | 101868522 |
| 20048320 | 20086382 | 1.58 | 99.8 | 03 | 2017-09-28 | 2017-10-05 | IBRUTINIB | 01 | N | SUNITINIB | 101038806 |
| 20048376 | 20086383 | 0 | 0 | Palliative (P) | null | 2017-01-04 | EVEROLIMUS | 01 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 100390085 |
| 20048387 | 20086384 | 1.63 | 66.6 | Palliative (P) | 2017-07-19 | 2017-07-23 | PEMBROLIZUMAB | 02 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100366242 |
| 20048404 | 20086385 | 1.77 | 48.4 | Adjuvant (A) | 2019-10-18 | 2019-10-18 | ESPAC-4 TRIAL | N | N | PLATO TRIAL | 100202914 |
| 20048411 | 20086386 | 1.66 | 46 | Palliative (P) | 2019-09-03 | 2019-09-05 | Palbociclib | 02 | N | IVA | 101001089 |
| 20048437 | 20086387 | 1.7 | 77.8 | 03 | 2019-01-27 | 2019-02-03 | Carboplatin + Pemetrexed | null | Y | CHLORAMBUCIL + RITUXIMAB | 100349866 |
| 20048459 | 20086388 | 1.76 | 79.4 | 03 | 2013-09-21 | 2019-03-13 | ECarboX | 02 | Y | SUNITINIB | 100490797 |
| 20048486 | 20086389 | 1.73 | 78.8 | 03 | 2019-02-04 | 2019-02-10 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | Y | ERIBULIN | 101173998 |
| 20048490 | 20086390 | 1.73 | 61.7 | Palliative (P) | 2016-03-05 | 2016-03-13 | PLATO Trials | 02 | N | PLATO TRIAL | 100913682 |
| 20048492 | 20086391 | 1.72 | 79.4 | Adjuvant (A) | null | 2016-07-28 | SCOPE 2 TRIAL | N | N | IFOSFAMIDE | 100170592 |
| 20048534 | 20086392 | 1.73 | 62.3 | Palliative (P) | 2015-10-04 | 2015-10-22 | ECarboX | 02 | N | EOF | 100110275 |
| 20048536 | 20086393 | 1.73 | 63.5 | 03 | 2019-02-20 | 2019-02-20 | CARBOPLATIN + GEMCITABINE | 02 | N | GEMCARBO | 101199417 |
| 20048648 | 20086394 | 1.8 | 78.5 | null | 2017-02-07 | 2017-02-13 | CHOP R - 21 days | 02 | N | EVEROLIMUS | 101452001 |
| 20048665 | 20086396 | 1.69 | 112 | Palliative (P) | 2019-02-05 | 2019-02-19 | REGORAFENIB | 02 | N | ABC-08 TRIAL | 100880269 |
| 20048711 | 20086397 | 1.63 | 89.2 | Palliative (P) | 2018-02-18 | 2018-03-04 | FCarboSt | 02 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 100796605 |
| 20048719 | 20086398 | null | 87 | 03 | 2018-02-20 | 2018-02-20 | Abiraterone | 02 | null | CAPECITABINE + STREPTOZOCIN | 101297643 |
| 20048721 | 20086399 | 1.69 | 73.4 | 03 | 2017-11-16 | 2017-12-23 | Cisplatin +FU +Trastuzumab - Load | N | N | BENDAMUSTINE + RITUXIMAB | 101266698 |
| 20048729 | 20086400 | 1.8 | 71.7 | Palliative (P) | 2020-01-16 | 2020-01-27 | INTERAACT trial | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 101214108 |
| 20048731 | 20086401 | 1.59 | 71.5 | 03 | 2019-12-11 | 2019-12-24 | Nilotinib | 02 | N | DABRAFENIB + TRAMETINIB | 100235540 |
| 20048767 | 20086402 | 0 | 0 | 03 | null | 2017-02-15 | Hydroxycarbamide | 01 | N | ACTICCA-1 TRIAL | 100489053 |
| 20048784 | 20086403 | 1.62 | 9.5 | 03 | 2019-11-03 | 2019-11-05 | Capecitabine+Cisplatin+Streptozocin | 01 | Y | GO2 TRIAL | 101050725 |
| 20048789 | 20086404 | 1.72 | 69.1 | Palliative (P) | 2017-10-25 | 2017-10-30 | UKALL14- Maintenance + Imatinib | N | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 100172165 |
| 20048835 | 20086405 | 1.77 | 15.4 | Palliative (P) | 2017-10-06 | 2017-10-14 | VISMODEGIB | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101457127 |
| 20048912 | 20086406 | 1.84 | 78.2 | 03 | 2018-06-16 | 2018-06-16 | CARBOPLATIN + VINORELBINE | null | N | ABVD | 101613837 |